News

Some lung cancer patients may experience durable disease control even after discontinuing immunotherapy
A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...
Tumor byproduct blocks immune cells from fighting cancer, offering new treatment target
A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, ...
News-Medical.Net10h
Cancer immunotherapy effective across all ages despite immune differences
Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns ...
Lung Cancer Remains At Bay Long After Immune Therapy Is Dropped
MONDAY, April 21, 2025 (HealthDay News) — Immunotherapy might help keep lung cancer at bay for months or even years after the ...
Older adults respond well to immunotherapy despite age-related immune system differences, researchers find
Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune ...
Mirage News16h
Immunotherapy Effective in Seniors Despite Immune Changes
Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences ...
Johns Hopkins Medicine20h
Older Adults Respond Well to Immunotherapy Despite Age-Related Immune System Differences
Several states are reporting cases of measles, a highly contagious viral disease. Both children and adults can get measles.